GlassScriptPhysician profile
Ahmar Sajjad
NPI 1982066254
$4,729.39
in general payments reported to CMS, 2019-2025
19 companies · $1,296 in 2025
The $1,296 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,304 · 2022: $429 · 2023: $497 · 2024: $1,204 · 2025: $1,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,499 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,498.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $498.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $1,907.79 | 2021-2025 | Lensar Laser System |
| Glaukos Corporation | $1,029.83 | 2021-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idose, Radius |
| Alcon Vision LLC | $479.17 | 2022-2025 | Wavelight Refractive Suite, Hydrus Microstent, Rocklatan |
| Abbvie INC. | $247.28 | 2022-2025 | Durysta |
| Rxsight INC | $234.48 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Contact Lens |
| Dompe US, INC. | $189.65 | 2023-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $149.44 | 2021-2023 | Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $109.33 | 2023-2024 | Vyzulta, Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $101.14 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $48.14 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $40.04 | 2024-2025 | Acthar |
| Ocular Therapeutix, INC. | $38.41 | 2023-2024 | Dextenza |
| Ani Pharmaceuticals, INC. | $33.22 | 2024 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $25.70 | 2023 | |
| Allergan, INC. | $24.59 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $24.35 | 2025 | Iyuzeh |
| Sight Sciences, INC. | $20.95 | 2021 | |
| Harrow Eye, LLC | $13.62 | 2025 | Vevye |
| New World Medical,INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmar Sajjad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.